Repetitive Therapy with Levosimendan Effectively Reduces NT-proBNP Levels and NYHA-Class in Heart Failure Patients A Case Report

被引：1
|
作者：
Wechsler, Maximilian [1 ]
Schwinger, Robert H. G. [1 ]
机构：
[1] Lehrkrankenhaus Univ Regensburg, Kliniken Nordober Pfalz AG, Klinikum Weiden, Med Klin 2, Sollnerstr 16, D-92637 Weiden, Germany
来源：
AKTUELLE KARDIOLOGIE | 2022年 / 11卷 / 05期
关键词：
Levosimendan; NT-proBNP; chronical heartfailure; ICM; ESC GUIDELINES; DIAGNOSIS;
D O I：
10.1055/a-1799-7077
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since any cardiac decompensation with subsequent hospitalization worsens the prognosis of the patient further, it is important to prevent cardiac decompensations. A normal NT-proBNP value is a "rule-out" parameter for heart failure. Measurement of NT-proBNP may help to estimate the intraindividual risk of cardiac decompensation and may guide intensification of heart failure treatment. Levosimendan therapy in addition to OMT improves pump function and thus reduces the risk of cardiac decompensation. The present case illustrates the benefit of repetitive therapy with levosimendan in addition to OMT following ESC Guideline-directed treatment.
引用
收藏
页码：484 / 489
页数：6
相关论文
共 50 条
  • [1] Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
    Wechsler, Maximilian
    Schwinger, Robert H. G.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (03) : 529 - 537
  • [2] Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
    Maximilian Wechsler
    Robert H. G. Schwinger
    Drugs - Real World Outcomes, 2022, 9 : 529 - 537
  • [3] Correlation of levels of NT-proBNP and NYHA functional classification in patients with congestive heart failure.
    Adams, JE
    Ewald, G
    Berger, S
    Kroll, MH
    Nowatzke, WL
    Cole, TG
    CLINICAL CHEMISTRY, 2003, 49 (06) : A66 - A66
  • [4] Comparative study on the severity of heart failure based on NYHA heart failure classification and the levels of NT-proBNP, BNP and (NT-proBNP/BNP in pmol/L)
    Shimada, T.
    Sumiyoshi, T.
    Sasaki, S.
    Nagayama, M.
    Tobaru, T.
    Doi, O.
    Kambara, H.
    EUROPEAN HEART JOURNAL, 2011, 32 : 913 - 913
  • [5] Prognostic implications of NYHA class and NT-proBNP levels in mild heart failure: a PARADIGM-HF analysis
    Rohde, L. E.
    Zimerman, A.
    Claggett, B.
    Packer, M.
    Desai, A. S.
    Zile, M.
    Rouleau, J.
    Swedberg, K.
    Lefkowitz, M.
    Shi, V
    McMurray, J.
    Vaduganathan, M.
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2022, 43 : 891 - 891
  • [6] Variability of NT-ProBNP levels in patients with stable heart failure
    Araujo, J. P.
    Azevedo, A.
    Lourenco, P.
    Ferreira, A.
    Goncalves, F. Rocha
    Bettencourt, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 208 - 209
  • [7] Predictors of NT-proBNP response in primary care patients with heart failure and NT-proBNP guided therapy
    Erntell, H.
    Swedberg, K.
    Jorgensen, L.
    Dahlstrom, U.
    Persson, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S31 - S31
  • [8] NT-PROBNP GUIDED HEART FAILURE THERAPY
    Januzzi, James L., Jr.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S174 - S174
  • [9] Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure
    Conraads, VM
    Beckers, P
    Vaes, J
    Martin, M
    Van Hoof, V
    De Maeyer, C
    Possemiers, N
    Wuyts, FL
    Vrints, CJ
    EUROPEAN HEART JOURNAL, 2004, 25 (20) : 1797 - 1805
  • [10] The effect of perindopril on echocardiographic parameters, NYHA functional class and serum NT-proBNP values in patients with diastolic heart failure
    Yuksek, Umit
    Cerit, Levent
    Eren, Nihan Kahya
    Ergene, Oktay
    CARDIOVASCULAR JOURNAL OF AFRICA, 2019, 30 (04) : 222 - 227
12345